WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the availability of WebVDME™ 6.0, the latest release of the company’s leading strategic pharmacovigilance and signal management product. The new release includes more tools and features for discovering and investigating signals in greater depth, exploring varied combinations of factors that trigger adverse events and simplifying analysis of safety data. WebVDME is used by leading pharmaceutical and biotech companies as well as several regulatory agencies, many of which participated in the project as development or testing partners.
